This website uses cookies
Read our Privacy policy and Terms of use for more information.
Podcast
+1
/
Oct 30, 2026
From gaps in access and the daily burden of diabetes to advances in screening, technology, and new therapies, we dive into T1D care and what comes next.
Videos
+2
After years of severe insulin reactions, DKA, and medical dismissal, GJ shares her search for answers to a rare complication with type 1 diabetes.
Type 1 Diabetes
Oct 29, 2026
My story of living with rare insulin reactions, being dismissed by doctors for years, and fighting to find answers when the very treatment I need to survive becomes a threat to my life.
Sep 21, 2026
I unpack how routine, technology, trial and error, and working with a trusted diabetes educator have been the some of the the keys to my health journey while managing T1D.
Cure
Aug 7, 2026
Patient 7 of the Vertex VX-880 trial, talks about life after being "cured" of type 1 diabetes and the emotional toll of trusting her body again.
Jun 29, 2026
Commercial airline pilot, John Roth, shares how his T1D diagnosis nearly cost him his career and how he used modern technology to help advocate for change.
Clinical Trials
+4
Jun 23, 2026
A study from the University of Chicago made 12 people with type 1 diabetes insulin-independent, but a cure for the masses is still a long way off.
Research
Jun 10, 2026
Patient 9 of the Eledon trial, who received an islet cell transplant, talks about life after being "cured" of type 1 diabetes and the work still left to be done.
Jun 5, 2026
From cause to diagnoses to treatments and tech, there's a lot of similarities and differences between type 1 and type 2 diabetes worth knowing.
News
+3
May 29, 2026
Afrezza, the only inhalable mealtime insulin, is now available to children and adolescents signifying a step forward in pediatric diabetes care
ODT
May 25, 2026
We break down the science behind exercising with T1D, offer ideas and strategies to help improve your time in range, and how to diabetes technology can help.
Dexcom
+5
May 22, 2026
The G8's sleek design and new algorithm aims to solve past issues and is expected to be available to the public late 2027/early 2028.
Travel Tips
May 18, 2026
Stash tracks diabetes supplies with barcode scanning, low-stock alerts, trip planning, infusion site-tracking, and recall monitoring.
Apr 28, 2026
Sanofi's disease-modifying therapy can now be used in children as young as 1 year old, opening a new window to delay type 1 diabetes progression in the youngest patients.
Apr 27, 2026
Tandem's Control IQ+ becomes the only commercially available automated insulin delivery system approved for pregnancy use in the U.S.
Apr 24, 2026
The two have partnered to develop SC451, an investigational cell therapy aiming to restore the body’s ability to regulate glucose and eliminate the need for both insulin and immunosuppressive therapy.
Apr 14, 2026
Niia Essential demonstrated proof of concept, strong performance and accuracy, and zero insulin delivery failures in its first clinical study.
Apr 13, 2026
Nw operating in 20 states and Washington, D.C., Blue Circle Health is expanding free, comprehensive support for adults living with type 1 diabetes across the country.
Mar 30, 2026
The bill caps insulin costs, forces rebate transparency, and encourages competition to lower prescription prices overall.
Mar 25, 2026
True mastery of diabetes management doesn’t come only from using the data—it comes from experience, reflection, and having the right guide beside you.
Mar 16, 2026
A bill stalled in Congress and a promising clinical trial may together be the most important developments in type 1 diabetes treatment right now.
Mar 13, 2026
Approximately 1.5% of Omnipod 5 pods are impacted by a tubing issue that may cause insulin to leak inside the device.
Mar 10, 2026
The new Liberty feature allows people with type 1 diabetes to temporarily stop counting carbs or deliver boluses while CamAPS FX automatically manages glucose levels.
Type 2 Diabetes
Mar 6, 2026
Here's a list of our go-to accessories from coolers, cases, and patches, to snacks that help keep your diabetes management on track no matter where you go.
Feb 23, 2026
Encapsulated neonatal pig islet cells, implanted without immunosuppression in the OPF-310 trial, cut a type 1 diabetes patient’s insulin needs in half at six months, with further maturation expected.
